Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis

Objective To identify genetic associations with severity of radiographic damage in ankylosing spondylitis (AS). Method We studied 1537 AS cases of European descent; all fulfilled the modified New York Criteria. Radiographic severity was assessed from digitised lateral radiographs of the cervical and lumbar spine using the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS). A two-phase genotyping design was used. In phase 1, 498 single nucleotide polymorphisms (SNPs) were genotyped in 688 cases; these were selected to capture >90% of the common haplotypic variation in the exons, exon–intron boundaries, and 5 kb flanking DNA in the 5′ and 3′ UTR of 74 genes involved in anabolic or catabolic bone pathways. In phase 2, 15 SNPs exhibiting p<0.05 were genotyped in a further cohort of 830 AS cases; results were analysed both separately and in combination with the discovery phase data. Association was tested by contingency tables after separating the samples into ‘mild’ and ‘severe’ groups, defined as the bottom and top 40% by mSASSS, adjusted for gender and disease duration. Results Experiment-wise association was observed with the SNP rs8092336 (combined OR 0.32, p=1.2×10−5), which lies within RANK (receptor activator of NFκB), a gene involved in osteoclastogenesis, and in the interaction between T cells and dendritic cells. Association was also found with the SNP rs1236913 in PTGS1 (prostaglandin-endoperoxide synthase 1, cyclooxygenase 1), giving an OR of 0.53 (p=2.6×10−3). There was no observed association between radiographic severity and HLA-B*27. Conclusions These findings support roles for bone resorption and prostaglandins pathways in the osteoproliferative changes in AS.

[1]  M. Dougados,et al.  Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study , 2013, Annals of the rheumatic diseases.

[2]  Tae-Hwan Kim,et al.  HLA-B27 homozygosity has no influence on radiographic damage in ankylosing spondylitis: Observation Study of Korean spondyloArthropathy Registry (OSKAR) data. , 2013, Joint, bone, spine : revue du rhumatisme.

[3]  Peter Donnelly,et al.  Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci , 2013, Nature Genetics.

[4]  M. Dougados,et al.  SAT0248 Evolution of Radiographic Damage in Ankylosing Spondylitis Over 12 Years of Follow-Up , 2013 .

[5]  M. Weisman,et al.  Cervical Vertebral Squaring in Patients without Spondyloarthritis , 2012, The Journal of Rheumatology.

[6]  Antonio Martínez,et al.  Genetic polymorphisms inside and outside the MHC improve prediction of AS radiographic severity in addition to clinical variables. , 2012, Rheumatology.

[7]  P. Chang,et al.  ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis , 2012, Arthritis Research & Therapy.

[8]  Daniel L. Koller,et al.  Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture , 2012, Nature Genetics.

[9]  P. Rahman,et al.  Radiographic severity of ankylosing spondylitis is associated with polymorphism of the large multifunctional peptidase 2 gene in the Spondyloarthritis Research Consortium of Canada cohort. , 2012, Arthritis and rheumatism.

[10]  M. Dougados,et al.  Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis , 2012, Annals of the rheumatic diseases.

[11]  E. Märker-Hermann,et al.  Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort , 2012, Annals of the rheumatic diseases.

[12]  Jing Wu,et al.  A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis , 2011, Nature Genetics.

[13]  Antonio Martínez,et al.  ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. , 2011, Rheumatology.

[14]  Paul Weston,et al.  Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility , 2011, Nature Genetics.

[15]  M. González-Gay,et al.  Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease , 2011, Arthritis research & therapy.

[16]  M. Brown,et al.  Promise and pitfalls of the Immunochip , 2011, Arthritis research & therapy.

[17]  William D Fraser,et al.  Genome wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget’s disease of bone , 2010, Nature Genetics.

[18]  Michael M. Ward,et al.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci , 2010, Nature Genetics.

[19]  J. Malley,et al.  Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. , 2009, Arthritis and rheumatism.

[20]  E. Lee,et al.  Receptor activator of nuclear factor kappa B ligand-mediated osteoclastogenesis is elevated in ankylosing spondylitis. , 2009, Clinical and experimental rheumatology.

[21]  M. Dougados,et al.  Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine , 2008, Annals of the rheumatic diseases.

[22]  Kari Stefansson,et al.  Multiple genetic loci for bone mineral density and fractures. , 2008, The New England journal of medicine.

[23]  A. Skytthe,et al.  Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation , 2008, Scandinavian journal of rheumatology.

[24]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[25]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[26]  J Tuomilehto,et al.  Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis , 2005, Annals of the rheumatic diseases.

[27]  M. Dougados,et al.  Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. , 2005, Arthritis and rheumatism.

[28]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[29]  M. A. van 't Hof,et al.  Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system , 2004, Annals of the rheumatic diseases.

[30]  L. Bradbury,et al.  Concordance of disease severity among family members with ankylosing spondylitis? , 2004, The Journal of rheumatology.

[31]  L. Cardon,et al.  Is disease severity in ankylosing spondylitis genetically determined? , 2001, Arthritis & Rheumatism.

[32]  R. Wallace,et al.  Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis , 2000, Nature Genetics.

[33]  W. Dougall,et al.  RANK is essential for osteoclast and lymph node development. , 1999, Genes & development.

[34]  R. Steinman,et al.  TRANCE, a Tumor Necrosis Factor Family Member Critical for CD40 Ligand–independent T Helper Cell Activation , 1999, The Journal of experimental medicine.

[35]  P Wordsworth,et al.  Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. , 1997, Arthritis and rheumatism.

[36]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.

[37]  Boersma Jw Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone. , 1976 .

[38]  J. Boersma Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone. , 1976, Scandinavian journal of rheumatology.